Thursday, February 12, 2015

Some of the latest Lyme disease news stories

From Lyme Disease blogs
LymeDisease.org, publisher of The Lyme Times, advocates nationally for people with tick-borne diseases, educates the public, and helps fund medical research. We are the go-to source for news, information, and health policy analysis in the Lyme community. Become a member today.

Sunday, February 8, 2015

13 year-old paralyzed because of Lyme (TV news, France)

ENGLISH SUBTITLES 
13 year-old paralysed because of Lyme, finally diagnosed and treated by Prof Perronne and is now walking, writing and talking after 2 months of treatment.

Short but powerful news item on French National TV yesterday sat Feb 7th 2015


Friday, February 6, 2015

Lyme disease costs up to $1. 3 billion per year to treat, study finds

Date:
February 5, 2015
Source:
Johns Hopkins Bloomberg School of Public Health
Summary:
New research suggests that a prolonged illness associated with Lyme disease is more widespread and serious in some patients than previously understood.

Lyme disease, transmitted by a bite from a tick infected by the Borrelia burgdorferi bacteria, had long been considered easy to treat, usually requiring a single doctor's visit and a few weeks of antibiotics for most people.

But new research from the Johns Hopkins Bloomberg School of Public Health suggests that a prolonged illness associated with the disease is more widespread and serious in some patients than previously understood. With an estimated 240,000 to 440,000 new cases of the tick-borne illness diagnosed every year, the researchers found that Lyme disease costs the U.S. health care system between $712 million and $1.3 billion a year -- or nearly $3,000 per patient on average -- in return doctor visits and testing, likely to investigate the cause of some patients' lingering symptoms of fatigue, musculoskeletal pain and memory problems. These visits come after patients have finished their original course of antibiotics.

More: http://www.sciencedaily.com/releases/2015/02/150205095049.htm

Thursday, February 5, 2015

Smith Introduces National Lyme Disease Bill

New Jersey ranks 4th in U.S. in Lyme cases

Lyme Disease Association Backs Legislation

http://chrissmith.house.gov/news/documentsingle.aspx?DocumentID=397880

 

 

Washington, Feb 4 | Jeff Sagnip ((202) 225-3765) 

 

     Continuing the fight to better assist patients and families impacted by Lyme disease, Congressman Chris Smith (R-NJ) announced the re-introduction of his bipartisan bill to establish a federal Tick-Borne Diseases Advisory Committee to better deliver results for those living with this debilitating illness.

    "Lyme disease has been particularly devastating in New Jersey, where it is estimated that over 59,000 individuals have reported cases of Lyme over the past 15 years," Smith said. According to recent data, 95 percent of Lyme disease cases were reported from 14 states, and New Jersey was fourth highest.

     "We need to redouble our efforts to help Lyme patients and their families in need of real solutions," said Smith, co-chair of the House Lyme Disease Caucus who has worked on issues impacting the Lyme community since the early 1990s. "Lyme rates are increasing all over the country, yet many are unaware of the seriousness of this disease and its potentially far-reaching effects. If not diagnosed and treated early, Lyme disease can lead to chronic illness and can affect every system in the body."

    Smith and Rep. Collin Peterson (D-MN) are co-chairs of the House Lyme Disease Caucus—a bipartisan organization dedicated to educating Members of Congress and staff about Lyme and other tick-borne diseases, as well as advancing initiatives that are designed to help the estimated 363,000 Americans who suffer from Lyme disease each year.
 
     "This bill would ensure that experts and patients have a seat at the table when decisions are made impacting Lyme disease research, diagnostics and treatments," Smith said.

    Specifically, HR 665 tasks the Secretary of Health and Human Services with establishing a Tick-Borne Diseases Advisory Committee to enhance coordination and improve communication among federal agencies, medical professionals, and patients. The committee will operate in a transparent and open manner, advising the Secretary on Lyme disease policy and submitting annual reports on the Committee's activities.

    The Lyme Disease Association (LDA) is headquartered in Smith's district in Jackson Township Ocean County N.J. Pat Smith, President of the LDA, commended the legislation.

     "The LDA is pleased to have legislation introduced into the House which provides a tick-borne diseases advisory committee which is governed by FACA rules to ensure transparency and accountability and which provides at least 4 people at the table who represent the patient community: 2 from patient groups and 2 patients themselves or family members," said Pat Smith (no relation to Rep. Smith). "It also provides a seat for at least two health care providers, with relevant experience providing care for individuals with a broad range of acute and chronic tick-borne diseases."

     
In 2013, the CDC announced what Smith and the Lyme community already knew: only 10 percent of cases were being reported and the actual number of Lyme cases is well over 300,000—not 30,000 as CDC had previously insisted. This report has heightened the urgency for a coordinated, targeted effort to assist Lyme patients.

     "Designing the process to better focus on improving outcomes after a Lyme diagnosis will not only ensure more effective policies, but will help to raise the quality of life for patients and assist the loved ones who care for them," Smith said.

    Smith held the first ever congressional hearing on Lyme before the global health subcommittee he chairs, which focused on the disease in the U.S. and other nations.

                                           

Some details about the NY State Lyme Protection Amendment

Apparently the NY State amendment that protects LLMDs who are treating chronic Lyme and co-infections patients with long-term antibiotics is more controversial than I had thought. Here is a letter I found on a Lyme listserv I monitor.

-Bob


 Dear Friends and Associates,
 
I ask that you not get upset about what was posted on the LDA web site, they do not have the facts and were not involved. It will be answered by the NYS Coalition on Lyme and Tick-borne Disease who were directly involved and worked diligently on this.
 
This is what I wrote in response when it was posted:

"Obviously, those of us on the NYS Coalition on Lyme and Tick-borne Disease,  disagree with this assessment.  Just one simple example: the 2005 memo was no longer being honored by the OPMC, which was why almost every, if not, every single LLMD physician was being harassed. There would not have been a physician left in NYS to treat suffering patients.
 
I am certain the Coalition will answer this. 
It is indeed a sad day,

-Jill"

We have a lot of work to do in 2015 both in NYS and federally. WE MUST REMAIN POSITIVE AND MOVE FORWARD. We can not get things done when we do not work together. TOGETHER we are a powerful force. We must not allow this to break our community.
 
This may be shared.
 
Jill Auerbach
Hudson Valley Lyme Disease Association, Chairperson
NYS Coalition on Lyme and Tick-borne Disease, Member

Wednesday, February 4, 2015

What does a high Lyme IgM antibody mean?

Here's what Dr. Joseph Jemsek has to say on the subject (on his website):

In virtually all infections, the IgM class of antibody (immunoglobulin) appears first and therefore represents a marker for an early infection. In most immune models, the IgM antibody gives way to the well-known IgG antibody class, usually regarded as the major enduring antibody response in chronic infectious diseases or other immune models. In almost all infection models, after just a few weeks, the IgM antibody level wanes to the point of being non-detectable and does not recur. However, a confounding fact in Bb infections is that the IgM antibody may persist for years, a very unusual situation in most disease states. Logically, one would have to conclude that this reflects an ongoing reactivation or persisting and continually renewing infectious state of Bb infection. Most active diagnostic laboratories involved with LD tend to agree with this notion. Therefore, the Jemsek Specialty Clinic acknowledges that a persistently positive IgM antibody response may qualify as laboratory confirmation for an active LD case. 

Tuesday, February 3, 2015

Candida may work synergistically with H pylori

Many Lyme patients seem to have problems with H pylori and candida and some have systemic candida. Chronic Fatigue Syndrome patients also have problems with candida. This article suggets that candida may be providing a home for very resistant bacteria. 



Monday, February 2, 2015

Suicide and Tick-borne Illness - Free conference in Cambridge, MA

I wish I could attend this conference. Maybe you can, or know someone who would want to. Please spread this announcement around. 

-Bob C. 


The next meeting of the Massachusetts Lyme Association (MLA) will focus on suicide and Lyme disease:

 

EVENT: Suicide & Tick-borne illness

 

DATE: Saturday, February 7th1:00pm - 3:00pm. Future meetings will take place the first Saturday of every month at the same time and location.

 

LOCATION: Cambridge Spaulding Rehabilitation Center - 1575 Cambridge St., Cambridge, MA - Chapel Conference Room (Once inside the main doors, simply ask security for further directions to "Neuromuscular Infections Treatment & Rehab Interest Group,")

 

PARKING: Please note that since visitor parking is limited at the center, the alternative would be metered parking on Cambridge Street, so please have a few extra quarters in tow just in case. 

 

PUBLIC TRANSPORTATION: The Rehabilitation Center is a 10 minute walk from the Harvard Square Red Line T station. 

 

SPEAKERS:

 

Leo Shea III, Ph.D.: 

Title: Lyme, Mood Disorders and Suicidality

 

Leo J. Shea III, Ph.D. is President of Neuropsychological Evaluation and Treatment Services, P.C. with offices in New York City and Quincy, Massachusetts. His practice focuses on traumatic brain injury, tick-borne diseases,  forensic work and trauma and provides cognitive remediation and psychotherapy to individuals and families. He is a Senior Staff Psychologist and Clinical Associate Professor of Rehabilitation Medicine at Rusk Institute, a division of the New York University-Langone Medical Center, and is President of the International Lyme and Associated Diseases Educational Foundation (ILADEF).

 

Ron White, LICSW: 

Title: "Helping Those at Risk for Suicide"

 

Ron White, LICSW is the Chief Program Officer of Samaritans, Inc. with operational responsibilities for Crisis Services (phone, chat and text), Grief Support Services, and Community Education. Mr. White is responsible for the more than 500 people who volunteer at Samaritans in a direct service capacity. Mr. White received his Bachelor of Social Welfare and Master of Social Work degrees from The Ohio State University and is currently a Licensed Independent Clinical Social Worker (LICSW) in Massachusetts. Mr. White has spent much of his professional career managing service centers both in the US and abroad. He joined Samaritans as Director of Programs and Services in 2007 and was promoted to his current position in 2009. He has also served as a member of the Massachusetts Gay, Lesbian Bisexual and Transgender Youth Commission under appointment from the Massachusetts Suicide Prevention Coalition. Mr. White is also co-chair of the Greater Boston Regional Coalition for Suicide Prevention and a member of the executive committee of the Massachusetts Coalition for Suicide Prevention. Mr. White currently serves on the executive committee of the National Association of Crisis Organization Directors (NASCOD) and on the Standards Training and Practices subcommittee for The National Suicide Prevention Lifeline.

 

Sheila Statlender, Ph.D., Moderator

Sheila Statlender, Ph.D. is a clinical psychologist in practice in Newton, Massachusetts for more than 25 years. She is a member of the American Psychological Association, the Massachusetts Psychological Association, the National Register of Health Providers in Psychology, and the International Lyme and Associated Diseases Society. Dr. Statlender specializes in the impact of chronic illness, including academic, vocational and personal adjustment issues, and provides individual and family counseling to many patients diagnosed with tick borne disease. Dr. Statlender has presented at a number of professional conferences and workshops, participated in the Boston Bar Association Task Force on Professional Challenges and Family Needs, and was a governor-appointed member of the Commission to Conduct an Investigation and Study of the Incidence and Impacts of Lyme Disease in the Commonwealth of Massachusetts. On a personal note, Dr. Statlender is the mother of three young adults who were diagnosed with Lyme disease as children.

 

Dr. Statlender also has offered some short articles as food for thought. The first three present the idea that depression is not just "in your head" but may be the result of physiological, inflammatory, and/or infectious agents. The articles are:

 

 

 

 

The remaining articles pertain directly to the impact of Lyme disease on depression, mood and neuropsychiatric symptoms, and are written by physicians who have treated many Lyme patients:

 

1.  Brian Fallon, MD & Jennifer Nields, MD: 

 

Lyme disease: A neuropsychiatric illness. 

http://www.jersey.net/~joebur/introfal.htm  

 

2.  Dan Cameron, MD, current president of ILADS:

 

Lyme Disease and Suicide, An Ignored Problem

http://ireport.cnn.com/docs/DOC-1037462

 

3.   Robert Bransfield, MD, from his website and other sources:

 

"Lyme, Depression, and Suicide"


http://www.mentalhealthandillness.com/Articles/LymeDepressionAndSuicide.htm

 

For more information about the MLA and upcoming programs, go to www.masslyme.org

 

There is no admission charge for this program. 

 

Wednesday, January 28, 2015

Higher dementia risk linked to more use of common drugs

 January 27, 2015
 ...................................
A large study links a significantly increased risk for developing dementia, including Alzheimer's disease, to taking commonly used medications with anticholinergic effects at higher doses or for a longer time. Many older people take these medications, which include nonprescription diphenhydramine (Benadryl) and related drugs. JAMA Internal Medicine published the report, called "Cumulative Use of Strong [...]

MORE | http://kurzweilai.us1.list-manage.com/track/click?u=aad1a7eea269839c7d10845e8&id=ac31617b45&e=f925541f84

More on the recent NY State Lyme law

 
Amazing, dedicated, brilliant, that's NY State Assembly member Didi Barrett! We asked her to sponsor the NYS Lyme bill, and her skill and determination successfully brought it into NYS law, helping tens of thousands of sick patients obtain treatment. This will show the way for other states! There's more work to do.

We are DELIGHTED that you are back in Albany working for ALL NYS citizens. Let's get Albany cleaned up, with more people like you! THANK YOU FOR EVERYTHING!
 
also see: